SG7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SAGE Therapeutics Inc

Watchlist Manager

Watchlist

Price: 7.58 EUR Market Closed

Market Cap: €456.2m

S	SAGE Therapeutics Inc F:SG7	US
C	Clariant AG F:CLRN	CH
	Amaroq Minerals Ltd F:72Q	CA
	Ausgold Ltd F:AU4	AU
N	NLC India Ltd BSE:513683	IN
J	JAKKS Pacific Inc F:JP1A	US
	Globalstar Inc F:P8S	US
A	Alma Media Oyj F:A4M	FI

Profitability Summary

SAGE Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Strong 3Y Average Gross Margin

80%

Negative Operating Margin

-430%

Negative 3Y Average Operating Margin

-1.778%

Operating Margin is Increasing

-6.163% > -430%

Negative Net Margin

-428%

Negative 3Y Average Net Margin

-1.727%

Net Margin is Increasing

-5.931% > -428%

Negative Free Cash Flow Margin

-411%

Negative 3Y Average Free Cash Flow Margin

-1.491%

Free Cash Flow Margin is Increasing

-5.391% > -411%

Negative ROE

-60%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-750%

ROIC is Increasing

-762% > -616%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.